Azinomycin B (CHEM057931)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-03-31 20:59:12 UTC | ||||||||
| Update Date | 2026-08-22 10:34:33 UTC | ||||||||
| Accession Number | CHEM057931 | ||||||||
| Identification | |||||||||
| Common Name | Azinomycin B | ||||||||
| Class | Small Molecule | ||||||||
| Description | Azinomycin B is an organic compound with the chemical formula C31H33N3O11. Azinomycin B belongs to the naphthalenecarboxylic acids and derivatives, a subclass of naphthalenes within the organic compounds. With an average molecular weight of 623.62 g/mol, Azinomycin B is a heavy molecule. This substance is found in or released from one recorded source, specifically antibiotics within healthcare, pharmaceuticals, and veterinary products. Recorded exposure routes for this compound include inhalation and oral administration. | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type | Not Available | ||||||||
| Chemical Structure |  | ||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C31H33N3O11 | ||||||||
| Average Molecular Mass | 623.615 g/mol | ||||||||
| Monoisotopic Mass | 623.212 g/mol | ||||||||
| CAS Registry Number | 106486-76-4;1403-28-7;1403-26-5;81553-83-5 | ||||||||
| IUPAC Name | [(1S)-2-[[(1E)-1-[(1S,2R,3R)-3-acetyloxy-2-hydroxy-5-azabicyclo[3.1.0]hexan-4-ylidene]-2-[[(Z)-1-hydroxy-3-oxobut-1-en-2-yl]amino]-2-oxoethyl]amino]-1-[(2S)-2-methyloxiran-2-yl]-2-oxoethyl] 3-methoxy-5-methylnaphthalene-1-carboxylate | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | COC1=CC2=C(C=CC=C2C)C(=C1)C(=O)O[C@H](C(=O)NC(C(=O)NC(C=O)C(C)=O)=C1/[C@@H](OC(C)=O)[C@H](O)[C@@H]2CN12)[C@]1(C)CO1 | ||||||||
| InChI Identifier | InChI=1S/C31H33N3O11/c1-14-7-6-8-18-19(14)9-17(42-5)10-20(18)30(41)45-27(31(4)13-43-31)29(40)33-23(28(39)32-21(12-35)15(2)36)24-26(44-16(3)37)25(38)22-11-34(22)24/h6-10,12,22,25-27,35,38H,11,13H2,1-5H3,(H,32,39)(H,33,40)/b21-12-,24-23+/t22-,25+,26+,27+,31-,34?/m0/s1 | ||||||||
| InChI Key | QIKVYJOCQXXRSJ-PKDLRSQSSA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways | Not Available | ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | Not Available | ||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra | Not Available | ||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||
